NICE and Manchester NHS Trust partner on RWE and digital guidance

The National Institute for Health and Care Excellence and Manchester University NHS Foundation Trust have announced a two-year partnership to explore how clinical guidance, real-world evidence and digital technologies can support healthcare delivery. The collaboration will focus on integrating guidance into clinical systems, generating evidence to inform health technology assessments, and exploring opportunities for earlier evaluation of emerging healthcare innovations.
The Baseline
- The collaboration brings together NICE’s expertise in evidence assessment and guidance development with MFT’s clinical, research and digital infrastructure.
- An initial project will explore developing a ‘NICE guidance agent’ within MFT’s electronic patient record system to provide clinicians with access to relevant recommendations.
- The collaboration will also explore real-world evidence generation and earlier evaluation of emerging healthcare technologies, with findings potentially informing wider NHS practice.
The two-year collaboration will involve practical projects examining how evidence and clinical guidance can be used within NHS services. Manchester University NHS Foundation Trust (MFT) will provide a setting for testing approaches in routine healthcare delivery, allowing the organisations to examine their implementation and potential applicability across the wider NHS.
A central priority is to explore how NICE recommendations can be made more accessible within routine clinical care. The organizations will investigate integrating guidance into MFT’s electronic patient record system, Hive, which uses Epic software, with the aim of enabling clinicians to access relevant recommendations within their existing workflows rather than searching for them separately. The partnership will also consider how patients can access information relevant to their care.
An initial project will investigate the development of a ‘NICE guidance agent’ within the Hive system. Drawing on NICE recommendations, the proposed tool would provide clinicians with relevant evidence and advice at the point of care. The project will explore how the proposed tool could be integrated into clinical systems and whether findings could inform approaches to delivering guidance elsewhere in the NHS.
Dr Clare Morgan, Director of Impact and Partnerships, NICE, outlined the intended benefit:
“Our ambition is to put NICE’s trusted, evidence-based knowledge at the fingertips of the people who need it, when they need it.”
The partnership will also focus on generating real-world evidence (RWE) to inform NICE’s assessments of new treatments and technologies and the development of future guidance. Drawing on MFT’s clinical, research and digital infrastructure, the organizations will explore how data collected during routine healthcare delivery can contribute to these activities and help identify areas where further evidence is needed.
A related workstream will focus on sharing information about emerging technologies and challenges in healthcare delivery. By bringing together NICE’s national perspective on healthcare innovation and MFT’s experience of testing and implementing technologies, the organizations aim to identify opportunities for earlier evaluation and assess the potential implications for patients and NHS services.
Mark Cubbon, Chief Executive Officer, MFT, described how the partnership could support these activities:
“Through our electronic patient record and our established digital and research infrastructure, MFT provides a real-world NHS environment in which new approaches can be tested and evaluated at scale. Working with NICE gives us an opportunity to improve how guidance is used within our own services, while generating learning that could support implementation across the wider NHS.”
The findings from the two-year collaboration could inform how NICE guidance is delivered and how emerging healthcare technologies are evaluated and implemented across the NHS.
| Register for free today to become a member of The Evidence Base and receive the latest news straight to your inbox. |